跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irinotecan hydrochloride Injection 300 mg in 15 mL (4) - TGA Drug Approval Details
Approvals
/
TGA
/
Irinotecan hydrochloride Injection 300 mg in 15 mL (4)
Approved
STANDARD
Irinotecan hydrochloride Injection 300 mg in 15 mL (4)
Pfizer (Perth) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
70aedb2922c70d2c
Company
Pfizer (Perth) Pty Ltd
Type
Standard
Approval Details
Approval Id
70aedb2922c70d2c
Product Name
Irinotecan hydrochloride Injection 300 mg in 15 mL (4)
Artg Id
322684
Artg Name
Irinotecan hydrochloride Injection 300 mg in 15 mL (4)
Sponsor
Pfizer (Perth) Pty Ltd
Company Detail Path
/organization/pfizer-perth-pty-ltd
Artg Date
2019-09-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
70aedb2922c70d2c
Type
Standard
Back to TGA Approvals
